BioRestorative Therapies ... (BRTX)
NASDAQ: BRTX
· Real-Time Price · USD
1.73
-0.11 (-6.23%)
At close: May 13, 2025, 3:59 PM
1.77
2.02%
After-hours: May 13, 2025, 06:47 PM EDT
BioRestorative Therapies Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Product Revenue | 300K |
| Product Revenue Growth | n/a |
| Royalty Revenue | 101K |
| Royalty Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.07M | 1.18M | 1.26M | 3.04M | 2.52M | 2.26M | 2.21M | 4.3M | 4.01M | 3.65M | 3.62M | 4.29M | 3.85M | 3.46M | 3.41M | 14.91M | 693.55K | 374.23K | 219.03K | 658.66K | 1.77M | 1.45M | 1.72M | 1.9M | 1.83M | 857.23K | 1.71M | 1.84M | 1.37M | 1.27M | 1.98M | 1.69M | 1.13M | 1.06M | 1.55M | 1.21M | 2.3M | 919.46K | 884.43K | 1.33M |
| Selling, General, and Administrative Revenue Growth | -9.34% | -6.11% | -58.62% | +20.93% | +11.34% | +2.13% | -48.52% | +7.16% | +9.93% | +0.69% | -15.60% | +11.58% | +11.26% | +1.46% | -77.13% | +2049.43% | +85.33% | +70.85% | -66.75% | -62.83% | +22.45% | -15.77% | -9.69% | +3.89% | +113.61% | -50.00% | -6.95% | +34.98% | +7.57% | -35.85% | +17.02% | +50.25% | +5.74% | -31.38% | +28.12% | -47.41% | +150.28% | +3.96% | -33.38% | n/a |
| Research and Development Revenue | 1.66M | 1.32M | 1.29M | 1.06M | 680.63K | 874.82K | 967.89K | 1.51M | 673.62K | 989.17K | 1.08M | 775.34K | 165.5K | 237.41K | 160.9K | 165.25K | 177.91K | 251.04K | 261.55K | 186.33K | 415.79K | 409.81K | 441.72K | 455.01K | 375.77K | 357.44K | 372.81K | 407.13K | 245.2K | 490.65K | 610.73K | 805.85K | 752.66K | 656.17K | 608.69K | 866.04K | 630.07K | 615.65K | 452.49K | 406.86K |
| Research and Development Revenue Growth | +25.62% | +2.16% | +22.12% | +55.46% | -22.20% | -9.62% | -35.95% | +124.35% | -31.90% | -8.00% | +38.68% | +368.49% | -30.29% | +47.55% | -2.64% | -7.11% | -29.13% | -4.02% | +40.37% | -55.19% | +1.46% | -7.22% | -2.92% | +21.09% | +5.13% | -4.13% | -8.43% | +66.04% | -50.03% | -19.66% | -24.21% | +7.07% | +14.71% | +7.80% | -29.72% | +37.45% | +2.34% | +36.06% | +11.22% | n/a |